CAV3 Gene Rippling Muscle Disease Genetic Test
Test Name: CAV3 Gene Rippling Muscle Disease Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CAV3 Gene Rippling Muscle Disease NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Rippling Muscle Disease.
Test Details:
CAV3 gene rippling muscle disease (RMD) is a rare genetic disorder characterized by muscle stiffness and rippling contractions. It is caused by mutations in the CAV3 gene, which provides instructions for producing a protein called caveolin-3.
To diagnose CAV3 gene rippling muscle disease, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the rapid and cost-effective sequencing of large amounts of genetic material.
The NGS genetic test for CAV3 gene RMD involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variants in the CAV3 gene.
The results of the test can confirm the presence of CAV3 gene mutations, which are indicative of rippling muscle disease. This genetic test is useful in diagnosing CAV3 gene rippling muscle disease, as it can detect even rare mutations that may not be identified through other testing methods.
It can also help determine the specific genetic variant causing the disease, which can aid in prognosis and treatment planning.
It is important to note that genetic testing for CAV3 gene rippling muscle disease should be performed by a qualified healthcare professional or a genetic counselor, who can interpret the results and provide appropriate genetic counseling and guidance.
| Test Name | CAV3 Gene Rippling muscle disease Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CAV3 Gene Rippling muscle disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Rippling muscle disease |
| Test Details |
CAV3 gene rippling muscle disease (RMD) is a rare genetic disorder characterized by muscle stiffness and rippling contractions. It is caused by mutations in the CAV3 gene, which provides instructions for producing a protein called caveolin-3. To diagnose CAV3 gene rippling muscle disease, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the rapid and cost-effective sequencing of large amounts of genetic material. The NGS genetic test for CAV3 gene RMD involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variants in the CAV3 gene. The results of the test can confirm the presence of CAV3 gene mutations, which are indicative of rippling muscle disease. This genetic test is useful in diagnosing CAV3 gene rippling muscle disease, as it can detect even rare mutations that may not be identified through other testing methods. It can also help determine the specific genetic variant causing the disease, which can aid in prognosis and treatment planning. It is important to note that genetic testing for CAV3 gene rippling muscle disease should be performed by a qualified healthcare professional or a genetic counselor, who can interpret the results and provide appropriate genetic counseling and guidance. |
